Skip to content

Pulp regeneration after pulpectomy by transplantation of autologous pulp stem cells.

Pulp regeneration after pulpectomy by transplantation of autologous pulp stem cells. - Pulp regeneration with dental pulp stem cells.

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000009441
Enrollment
5
Registered
2012-12-03
Start date
2013-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

irreversible pulpitis

Interventions

transplantation of pulp stem cells with G-CSF

Sponsors

National Center for Geriatrics and Gerontology, Research Institute
Lead Sponsor
Aichi Gakuin University
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients to whom the research plan has been explained orally and by a document, and from whom the consent of his or her participation has been obtained directly by a doccument without any compulsion 2) Outpatients 3) Patients who have irreversible pulpitis in the single root canal 4) Patients who have unnesessary and/or discarded teeth (including wisdom tooth, the surplus dislocated tooth, expendientry extracted tooth for orthodontic treatment without occlusion) which can supply pulp tissue 5) Patients who have enough residual healthy tooth structure over alveolar bone, confirming by a X ray micrograph, completely preventing microleakage in the root canal by resin partitions 6) Patients who have no tooth fracture detected by a X ray micrograph 7) Patients who have no periapical radiolucency

Exclusion criteria

Exclusion criteria: 1) patients who have a difficulty in collecting peripheral blood 2) patients who has infection, such as virus, bacteria, fungus or mycoplasma 3) cardiovascular disease patients 4) patients taking anticoagulants or antiplatelet agents 5) diabetes (more than HbA1c 6.1%) 6) osteoporosis 7) pregnant woman, expectant pregnant woman 8) patients who have a past history of allergy with any antimicrobial agent or local anesthetia 9) patients who have a difficulty in getting the consent, such as mentally retarded or mentally illness persons 10) persons to whom the principal investigator of the clinical trial in charge consider to be inappropriate

Design outcomes

Primary

MeasureTime frame
systemic finding oral manifestation extraction socket finding blood test blood chemistry examination Urine chemistry examination periapical swelling tenderness, percussion pain

Secondary

MeasureTime frame
electric pulp test radio lucency at the apex psychroalgia, pain to hot and cold, spontaneous pain, tenderness, percussion pain

Countries

Japan

Contacts

Public ContactKoichiro Iohara

National Center for Geriatrics and Gerontoogy Department of Dental Rgenerative Medicine

iohara@ncgg.go.jp0562468684

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026